RGBPP 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-05-14

• Operating Expense were $212,774 for the three months ended March 31, 2026 and $ 172,414 for the same period ended 2025. The primary operating expense for 2026 consists of $ 178,454 of Consulting & Professional expenses. In the same period in previous year Consulting and Professional fees expenditure…

• Revenues from continuing operations were $118,129 for the six months ended March 31, 2026 which is essentially equivalent to Revenues from continuing operations for the same period ended 2025. $54,849 of revenue from related parties recognized during the six months ended March 31, 2026 consisted of …

• Operating Expense were $823,462 for the six months ended March 31, 2026 and $ 292,857 for the same period ended 2025. The primary operating expense for 2026 consists of $ 332,218 of Consulting & Professional expenses. In the same period in previous year Consulting and Professional fees expenditure w…

• Research and Development Expenses of $212,216 recognized by the Company for the six months ended March 31, 2026 consisted of :

• (a)$2,216 paid for Patent maintenance services provided by the Company’s patent attorney.

相对上期删除的文字 · 来源:10-Q · 2026-02-13

• Operating Expense were $610,689 for the three months ended December 31, 2025 and $ 120,443 for the same period ended 2024. The primarily operating expenses for 2025 consists of $ 210,000 of Research and Development expenses and $231,925 of General and Administrative Expenses. In the same period in p…

• Working capital deficit increased by $291,814 from September 30, 2025 to December 31, 2025, primarily due to increase in Derivative Liability.

• Net increase (decrease) in cash and cash equivalents $(64,977) $(581)

• Net cash used in operating activities for the three months ended December 31, 2025 was $197,941 compared to $66,379, for the same period ended 2024. The increase in cash used in operating activities is primarily attributable to increased operating expenses incurred by the Company during the three mo…

• Net cash generated by financing activities for the three months ended December 30, 2025 was $132,964 which consisted of proceeds from sales of newly issued common stock.